New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection - PubMed (original) (raw)

New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection

L Winner 3rd et al. Infect Immun. 1991 Mar.

Abstract

Secretory immunoglobulin A (sIgA) plays a role in defense against Vibrio cholerae and other microorganisms that infect mucosal surfaces, but it is not established whether sIgA alone can prevent disease. We report here a strategy for identifying the antigen specificities of monoclonal sIgA antibodies that are capable of providing such protection. IgA hybridomas were generated from Peyer's patch lymphocytes after oral immunization with V. cholerae Ogawa 395. A clone was selected that produced dimeric monoclonal IgA antibodies directed against an Ogawa-specific lipopolysaccharide carbohydrate antigen exposed on the bacterial surface. Hybridoma cells were used to produce subcutaneous "backpack" tumors in syngeneic mice, resulting in secretion of monoclonal sIgA onto mucosal surfaces. Neonatal mice bearing anti-lipopolysaccharide hybridoma backpack tumors were specifically protected against oral challenge with 100 50% lethal doses of virulent Ogawa 395 organisms. Thus, the IgA hybridoma backpack tumor method identifies protective epitopes in the mucosal system and demonstrates that a single monoclonal sIgA can be sufficient to protect against intestinal disease.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Microbiol Rev. 1983 Dec;47(4):510-50 - PubMed
    1. Rev Infect Dis. 1983 Sep-Oct;5 Suppl 4:S784-92 - PubMed
    1. Clin Immunol Immunopathol. 1982 Sep;24(3):342-50 - PubMed
    1. Infect Immun. 1980 Jun;28(3):893-8 - PubMed
    1. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7257-61 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources